Skip to main content
Erschienen in: Der Nervenarzt 3/2011

01.03.2011 | Leitthema

Neurobiologie der Zwangsstörung

verfasst von: S. Karch, PD Dr. O. Pogarell

Erschienen in: Der Nervenarzt | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die neurobiologische Forschung der vergangenen Jahrzehnte hat erheblich zum Verständnis der pathophysiologischen Grundlagen der Zwangsstörung und damit indirekt auch zur Optimierung der verschiedenen Therapiestrategien beigetragen. Eine Vielzahl funktionell-bildgebender Studien weist auf eine Funktionsstörung frontostriataler Netzwerke hin, die in einem orbitofrontostriatalen Modell der Zwangsstörung zusammengefasst werden kann. Es wird eine Dysfunktion parallel angelegter frontostriataler Verbindungen postuliert, die mit einem Ungleichgewicht zwischen direkten und indirekten Rückkopplungsschleifen zu einer Disinhibition thalamokortikaler Aktivität führt. Neurochemische Studien haben gezeigt, dass die Zwangsstörung mit Veränderungen zentral modulatorischer Transmittersysteme, insbesondere des Serotonin- und Dopaminsystems verbunden ist, die direkt oder indirekt zu der Dysregulation der neuronalen Netzwerke beitragen dürften. Die Aufklärung serotonerger und dopaminerger Veränderungen und deren Interaktionen sind unter pharmakotherapeutischen Gesichtspunkten von besonderem Interesse.
Literatur
1.
Zurück zum Zitat Adams KH, Hansen ES, Pinborg LH et al (2005) Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8:391–401PubMedCrossRef Adams KH, Hansen ES, Pinborg LH et al (2005) Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8:391–401PubMedCrossRef
2.
Zurück zum Zitat Brody AL, Saxena S, Schwartz JM et al (1998) FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 84:1–6PubMedCrossRef Brody AL, Saxena S, Schwartz JM et al (1998) FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 84:1–6PubMedCrossRef
3.
Zurück zum Zitat Chamberlain SR, Menzies L, Hampshire A et al (2008) Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives Science 321:421–422 Chamberlain SR, Menzies L, Hampshire A et al (2008) Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives Science 321:421–422
4.
Zurück zum Zitat Denys D, Zohar J, Westenberg HG (2004) The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 65(Suppl 14):11–17PubMed Denys D, Zohar J, Westenberg HG (2004) The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 65(Suppl 14):11–17PubMed
5.
Zurück zum Zitat Friedlander L, Desrocher M (2006) Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev 26:32–49PubMedCrossRef Friedlander L, Desrocher M (2006) Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev 26:32–49PubMedCrossRef
6.
Zurück zum Zitat Hegerl U, Henkel V, Pogarell O (2002) Neurobiologische Erklärungsansätze bei Zwangsstörungen. Psychotherapie 7:228–233 Hegerl U, Henkel V, Pogarell O (2002) Neurobiologische Erklärungsansätze bei Zwangsstörungen. Psychotherapie 7:228–233
7.
Zurück zum Zitat Hoehn-Saric R, Schlaepfer TE, Greenberg BD et al (2001) Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Res 108:89–100PubMedCrossRef Hoehn-Saric R, Schlaepfer TE, Greenberg BD et al (2001) Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Res 108:89–100PubMedCrossRef
8.
Zurück zum Zitat Hollander E, Prohovnik I, Stein DJ (1995) Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 7:485–490PubMed Hollander E, Prohovnik I, Stein DJ (1995) Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 7:485–490PubMed
9.
Zurück zum Zitat Kim CH, Cheon KA, Koo MS et al (2007) Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors. Neuropsychobiology 55:156–162PubMedCrossRef Kim CH, Cheon KA, Koo MS et al (2007) Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors. Neuropsychobiology 55:156–162PubMedCrossRef
10.
Zurück zum Zitat Kwon JS, Jang JH, Choi JS, Kang DH (2009) Neuroimaging in obsessive-compulsive disorder. Expert Rev Neurother 9:255–269PubMedCrossRef Kwon JS, Jang JH, Choi JS, Kang DH (2009) Neuroimaging in obsessive-compulsive disorder. Expert Rev Neurother 9:255–269PubMedCrossRef
11.
Zurück zum Zitat Mataix-Cols D, Wooderson S, Lawrence N et al (2004) Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 61:564–576PubMedCrossRef Mataix-Cols D, Wooderson S, Lawrence N et al (2004) Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 61:564–576PubMedCrossRef
12.
Zurück zum Zitat Mataix-Cols D, Rosario-Campos MC, Leckman JF (2005) A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 162:228–238PubMedCrossRef Mataix-Cols D, Rosario-Campos MC, Leckman JF (2005) A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 162:228–238PubMedCrossRef
13.
Zurück zum Zitat Molina V, Montz R, Martin-Loeches M et al (1995) Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J Nucl Med 36:2234–2238PubMed Molina V, Montz R, Martin-Loeches M et al (1995) Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J Nucl Med 36:2234–2238PubMed
14.
Zurück zum Zitat Nakatani E, Nakgawa A, Ohara Y et al (2003) Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res 124:113–120PubMedCrossRef Nakatani E, Nakgawa A, Ohara Y et al (2003) Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res 124:113–120PubMedCrossRef
15.
Zurück zum Zitat Nielen MM, Boer JA den, Smid HG (2009) Patients with obsessive-compulsive disorder are impaired in associative learning based on external feedback. Psychol Med 39:1519–1526PubMedCrossRef Nielen MM, Boer JA den, Smid HG (2009) Patients with obsessive-compulsive disorder are impaired in associative learning based on external feedback. Psychol Med 39:1519–1526PubMedCrossRef
16.
Zurück zum Zitat Page LA, Rubia K, Deeley Q et al (2009) A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res 174:202–209PubMedCrossRef Page LA, Rubia K, Deeley Q et al (2009) A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res 174:202–209PubMedCrossRef
17.
Zurück zum Zitat Penades R, Catalan R, Rubia K et al (2007) Impaired response inhibition in obsessive compulsive disorder. Eur Psychiatry 22:404–410PubMedCrossRef Penades R, Catalan R, Rubia K et al (2007) Impaired response inhibition in obsessive compulsive disorder. Eur Psychiatry 22:404–410PubMedCrossRef
18.
Zurück zum Zitat Phillips ML, Marks IM, Senior C et al (2000) A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med 30:1037–1050PubMedCrossRef Phillips ML, Marks IM, Senior C et al (2000) A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med 30:1037–1050PubMedCrossRef
19.
Zurück zum Zitat Pogarell O, Hamann C, Popperl G et al (2003) Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry 54:1406–1413PubMedCrossRef Pogarell O, Hamann C, Popperl G et al (2003) Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry 54:1406–1413PubMedCrossRef
20.
Zurück zum Zitat Remijnse PL, Nielen MM, Balkom AJ van et al (2006) Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder Arch Gen Psychiatry 63:1225–1236 Remijnse PL, Nielen MM, Balkom AJ van et al (2006) Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder Arch Gen Psychiatry 63:1225–1236
21.
Zurück zum Zitat Sanematsu H, Nakao T, Yoshiura T et al (2010) Predictors of treatment response to fluvoxamine in obsessive-compulsive disorder: an fMRI study J Psychiatr Res 44:193–200 Sanematsu H, Nakao T, Yoshiura T et al (2010) Predictors of treatment response to fluvoxamine in obsessive-compulsive disorder: an fMRI study J Psychiatr Res 44:193–200
22.
Zurück zum Zitat Saxena S, Brody AL, Schwartz JM, Baxter LR (1998) Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 35 (Suppl):26–37 Saxena S, Brody AL, Schwartz JM, Baxter LR (1998) Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 35 (Suppl):26–37
23.
Zurück zum Zitat Saxena S, Brody AL, Maidment KM et al (2004) Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 161:1038–1048PubMedCrossRef Saxena S, Brody AL, Maidment KM et al (2004) Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 161:1038–1048PubMedCrossRef
24.
Zurück zum Zitat Schienle A, Schafer A, Stark R et al (2005) Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures. Int J Psychophysiol 57:69–77PubMedCrossRef Schienle A, Schafer A, Stark R et al (2005) Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures. Int J Psychophysiol 57:69–77PubMedCrossRef
25.
Zurück zum Zitat Schiepek G, Tominschek I, Karch S et al (2007) [Neuroimaging and the neurobiology of obsessive-compulsive disorder.] Psychother Psychosom Med Psychol 57:379–394 Schiepek G, Tominschek I, Karch S et al (2007) [Neuroimaging and the neurobiology of obsessive-compulsive disorder.] Psychother Psychosom Med Psychol 57:379–394
26.
Zurück zum Zitat Schiepek G, Tominschek I, Karch S et al (2009) A controlled single case study with repeated fMRI measurements during the treatment of a patient with obsessive-compulsive disorder: testing the nonlinear dynamics approach to psychotherapy. World J Biol Psychiatry 10:658–668PubMedCrossRef Schiepek G, Tominschek I, Karch S et al (2009) A controlled single case study with repeated fMRI measurements during the treatment of a patient with obsessive-compulsive disorder: testing the nonlinear dynamics approach to psychotherapy. World J Biol Psychiatry 10:658–668PubMedCrossRef
27.
Zurück zum Zitat Shmelkov SV, Hormigo A, Jing D et al (2010) Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 16:598–602PubMedCrossRef Shmelkov SV, Hormigo A, Jing D et al (2010) Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 16:598–602PubMedCrossRef
28.
Zurück zum Zitat Swedo SE, Pietrini P, Leonard HL et al (1992) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 49:690–694PubMed Swedo SE, Pietrini P, Leonard HL et al (1992) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 49:690–694PubMed
29.
Zurück zum Zitat Ursu S, Stenger VA, Shear MK et al (2003) Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 14:347–353PubMedCrossRef Ursu S, Stenger VA, Shear MK et al (2003) Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 14:347–353PubMedCrossRef
30.
Zurück zum Zitat Heuvel OA van den, Remijnse PL, Mataix-Cols D et al (2009) The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 132:853–868PubMedCrossRef Heuvel OA van den, Remijnse PL, Mataix-Cols D et al (2009) The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 132:853–868PubMedCrossRef
31.
Zurück zum Zitat Welch JM, Lu J, Rodriguiz RM et al (2007) Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 448:894–900PubMedCrossRef Welch JM, Lu J, Rodriguiz RM et al (2007) Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 448:894–900PubMedCrossRef
32.
Zurück zum Zitat Westenberg HG, Fineberg NA, Denys D (2007) Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 12:14–27PubMed Westenberg HG, Fineberg NA, Denys D (2007) Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 12:14–27PubMed
33.
Zurück zum Zitat Whiteside SP, Port JD, Abramowitz JS (2004) A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 132:69–79PubMedCrossRef Whiteside SP, Port JD, Abramowitz JS (2004) A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 132:69–79PubMedCrossRef
Metadaten
Titel
Neurobiologie der Zwangsstörung
verfasst von
S. Karch
PD Dr. O. Pogarell
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Der Nervenarzt / Ausgabe 3/2011
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-010-2964-1

Weitere Artikel der Ausgabe 3/2011

Der Nervenarzt 3/2011 Zur Ausgabe

CME Weiterbildung · Zertifizierte Fortbildung

Psychoonkologie – psychosoziale Onkologie